Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetate Ringer's solution (1% glucose) is an intravenous crystalloid solution used perioperatively, particularly in women undergoing cesarean section. It is a balanced electrolyte solution containing sodium, potassium, calcium, and chloride, with acetate serving as a buffering agent that is metabolized to bicarbonate in the body. The inclusion of 1% glucose (dextrose) provides a metabolic substrate intended to maintain blood glucose homeostasis in both the mother and the neonate. This specific concentration aims to prevent neonatal hypoglycemia while avoiding the risks of maternal or fetal hyperglycemia associated with higher glucose concentrations (e.g., 5%). It is primarily used for fluid replacement and electrolyte maintenance during surgical procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetate ringer's solution.